MIRA INFORM REPORT

 

IDENTIFICATION DETAILS

 

Name :

ACEBRIGHT (INDIA) PHARMA PRIVATE LIMITED [w.e.f.24.04.2012]

 

 

Formerly Known As :

CDYMAX (INDIA) PHARMA PRIVATE LIMITED [w.e.f.06.08.2009]

 

INTERMED LABS PRIVATE LIMITED

 

 

Country :

India

 

 

Financials (as on) :

31.03.2013

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

BLRI00919C

 

 

PAN No.:

[Permanent Account No.]

AAACI8027N

 

 

Legal Form :

Private Limited Liability Company

 

 

No. of Employees :

60 [Approximately]

 

 

BUSINESS DETAILS

 

Line of Business :

Manufacturer and Exporter of Active Pharmaceutical Ingredients.

 

 

Exports :

 

Products :

Finished Goods

Countries :

·         South Africa

·         Europe

 

 

Imports :

 

Products :

Raw Material

Countries :

·         China

 

 

Terms :

 

Selling :

Cash and Advance Payment

 

 

Purchasing :

Cash and Advance Payment

 

 

PRODUCTION STATUS AS ON 31.03.2013

 

Particulars

Unit

Licensed Capacity

Installed Capacity

Actual Production

 

 

 

 

 

Bulk Drugs

M.T. Per Annum

NA

200

14.25

 

 

 

 

 

 

NOTES:

The installed capacity is as certified by management and verified by Auditors since this is a Technical matter.

 

 

GENERAL INFORMATION

 

Customers :

Wholesalers, Retailers and End Users

 

 

No. of Employees :

60 [Approximately]

 

 

Bankers :

·         Corporation Bank

Industrial Finance Branch No.30, 1st Floor, 2nd Cr, Rallaram Memorial Building, CSI Compound Mission Road, Bangalore - 560027, Karnataka, India

 

 

Facilities :

SECURED LOANS

31.03.2013

(Rs. In Millions)

31.03.2012

(Rs. In Millions)

LONG-TERM BORROWINGS

 

 

Term loan from Corporation Bank, Industrial Finance Branch

86.792

121.793

Interest on Term Loan payable

0.998

1.438

SHORT TERM BORROWINGS

 

 

CC Account No. 30009 from Corporation Bank, Industrial Finance Branch

43.250

48.027

Industrial and Commercial Bank of China - Term Loan

550.000

0.000

 

 

 

Total

 

681.040

171.258

 

 

UNSECURED LOANS

31.03.2013

(Rs. In Millions)

31.03.2012

(Rs. In Millions)

LONG-TERM BORROWINGS

 

 

From Corporate Bodies

Couplet Limited

105.513

94.366

Interest on Loan [Couplet Limited]

1.267

1.463

 

 

 

Total

 

106.780

95.829

 

 

 

Banking Relations :

 

 

 

Auditors :

 

Name :

R. Natarajan

Chartered Accountant

Address :

#19/1, 2nd Floor, 6th Main, 9th Cross, Malleshwaram, Bangalore – 560003, Karnataka, India

Telefax :

91-80-23348770

Mobile No.:

91-9448067041

E-Mail :

natarajan9@gmail.com

PAN No.:

AANPR6508D

 

 

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

 

AS ON 21.09.2013

 

Names of Shareholders

 

No. of Shares

 

Medsyn Laboratories Private Limited, India

 

8775

Couplet Limited, British Virginia Islands

 

325225

Manorama Avinash

 

1

 

 

 

Total

 

 

334001

 


FINANCIAL DATA

[all figures are in Rupees Millions]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

31.03.2013

31.03.2012

31.03.2011

I.        EQUITY AND LIABILITIES

 

 

 

(1)Shareholders' Funds

 

 

 

(a) Share Capital

33.400

33.400

23.400

(b) Reserves & Surplus

115.272

334.643

248.385

(c) Money received against share warrants

0.000

0.000

0.000

 

 

 

 

(2) Share Application money pending allotment

0.000

0.000

0.000

Total Shareholders’ Funds (1) + (2)

148.672

368.043

271.785

 

 

 

 

(3) Non-Current Liabilities

 

 

 

(a) long-term borrowings

194.570

219.060

386.325

(b) Deferred tax liabilities (Net)

8.907

10.652

1.596

(c) Other long term liabilities

0.000

0.000

0.000

(d) long-term provisions

31.033

31.033

31.033

Total Non-current Liabilities (3)

234.510

260.745

418.954

 

 

 

 

(4) Current Liabilities

 

 

 

(a) Short term borrowings

593.250

48.027

20.530

(b) Trade payables

411.070

265.211

58.790

(c) Other current liabilities

3.184

0.810

3.851

(d) Short-term provisions

16.006

13.030

7.545

Total Current Liabilities (4)

1023.510

327.078

90.716

 

 

 

 

TOTAL

1406.692

955.866

781.455

 

 

 

 

II.      ASSETS

 

 

 

(1) Non-current assets

 

 

 

(a) Fixed Assets

 

 

 

(i) Tangible assets

687.351

492.054

64.043

(ii) Intangible Assets

0.000

0.000

0.000

(iii) Capital work-in-progress

31.991

53.267

347.801

(iv) Intangible assets under development

0.000

0.000

0.000

(b) Non-current Investments

0.014

0.014

0.014

(c) Deferred tax assets (net)

0.000

0.000

0.000

(d)  Long-term Loan and Advances

157.408

146.254

135.171

(e) Other Non-current assets

0.000

0.000

0.000

Total Non-Current Assets

876.764

691.589

547.029

 

 

 

 

(2) Current assets

 

 

 

(a) Current investments

0.000

0.000

0.000

(b) Inventories

296.161

146.155

96.544

(c) Trade receivables

119.882

36.148

83.244

(d) Cash and cash equivalents

0.766

0.176

0.136

(e) Short-term loans and advances

113.119

81.798

54.502

(f) Other current assets

0.000

0.000

0.000

Total Current Assets

529.928

264.277

234.426

 

 

 

 

TOTAL

1406.692

955.866

781.455

 

 

PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

 

31.03.2013

31.03.2012

31.03.2011

 

SALES

 

 

 

 

 

Income

598.437

451.606

411.952

 

 

Other Income

0.761

0.553

44.429

 

 

TOTAL                                    

599.198

452.159

456.381

 

 

 

 

 

Less

EXPENSES

 

 

 

 

 

TOTAL                                    

661.802

408.821

429.092

 

 

 

 

 

Less

PROFIT/ [LOSS] BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION

(62.604)

43.338

27.289

 

 

 

 

 

Less

FINANCIAL EXPENSES                        

72.169

38.633

4.808

 

 

 

 

 

 

PROFIT/ [LOSS] BEFORE TAX, DEPRECIATION AND AMORTISATION

(134.773)

4.705

22.481

 

 

 

 

 

Less/ Add

DEPRECIATION/ AMORTISATION                    

86.211

38.465

5.552

 

 

 

 

 

Less

PRIOR PERIOD EXPENSES

0.132

0.000

1.697

 

 

 

 

 

 

PROFIT/ [LOSS] BEFORE TAX

(221.116)

(33.760)

15.232

 

 

 

 

 

Less

TAX                                                                 

(1.744)

(9.056)

5.293

 

 

 

 

 

 

PROFIT/ [LOSS] AFTER TAX

(219.372)

(42.816)

9.939

 

 

 

 

 

Add

PREVIOUS YEARS’ BALANCE BROUGHT FORWARD

33.219

76.035

66.096

 

 

 

 

 

 

BALANCE CARRIED TO THE B/S

(186.153)

33.219

76.035

 

 

 

 

 

 

EARNINGS IN FOREIGN CURRENCY

 

 

 

 

 

Export Earnings

353.552

57.991

66.797

 

 

 

 

 

 

IMPORTS

 

 

 

 

 

Raw Materials

461.259

239.051

290.681

 

 

 

 

 

 

Earnings/ [Loss] Per Share (Rs.)

(656.80)

(128.19)

42.47

 

 

Particulars

 

 

 

31.03.2014

Sales Turnover

 

 

1410.000

 

 

 

[Due to more orders and more export business]

 

The above information has been parted by Mr. K. Jayakumar [Finance Manager]

 

 

PERFORMANCE

 

The Company’s total turnover for the year was Rs. 598.437 Millions (Previous year Rs. 451.606 Millions) comprising of Rs. 353.552 Millions from Export Sales, Rs. 244.885 Millions from Domestic Sales.   

 

 

RATING & COMMENTS

 

MIRA’s Rating :

B (30)

 

RATING

STATUS

PROPOSED CREDIT LINE

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

Small

 

 

Status :

Moderate

 

 

Payment Behaviour :

Slow but correct

 

 

Litigation :

Clear

 

 

RBI DEFAILTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available RBI Defaulters’ list.

 

 

LOCATIONS

 

Registered Office/ Factory :

116/117, KIADB Industrial Area, Jigani 2nd Phase, Bangalore – 560105, Karnataka, India

Tel. No.:

91-8110-415545

Fax No.:

91-8110-415540

E-Mail :

manorama@cdymax.in

manorama@acebright.in

k.jayakumar@acebright.in

Website :

http://www.acebright.in

 

 

Sales/ Marketing/ Branch Office :

B-Wing, 206/207, Classique Centre, Mahal Industrial Estate, Off Mahakali Caves Road, Andheri (East), Mumbai – 400093, Maharashtra, India

Tel. No.:

91-22-26879344

 

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.